• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性黑色素瘤细胞的增殖活性。

The proliferative activity of cells of malignant melanomas.

作者信息

Pierard G E, Pierard-Franchimont C

出版信息

Am J Dermatopathol. 1984 Summer;6 Suppl:317-23.

PMID:6528936
Abstract

The proliferative rates of cells of malignant melanomas were studied by autoradiography after incorporation of tritiated thymidine in them. There is a relationship between the proportion of melanomatous cells synthesizing DNA and the maximum thickness of the neoplasm. Our data suggest that there are two biologically distinct steps in the evolution of malignant melanoma that are closely related to the direction of growth of the neoplasm (horizontal or vertical) but unrelated to the clinicopathological pattern (superficial spreading, nodular or lentiginous). Malignant melanomas with high risk for early metastases are characterized by higher labeling indices for tritiated thymidine (greater than 1.5%) and by greater numbers of melanomatous cells synthesizing DNA (greater than 40/mm2 at the lateral margins of the neoplasms).

摘要

通过在恶性黑色素瘤细胞中掺入氚标记的胸腺嘧啶核苷后进行放射自显影,研究了恶性黑色素瘤细胞的增殖率。合成DNA的黑色素瘤细胞比例与肿瘤的最大厚度之间存在关联。我们的数据表明,恶性黑色素瘤的演变存在两个生物学上不同的阶段,这两个阶段与肿瘤的生长方向(水平或垂直)密切相关,但与临床病理模式(浅表扩散型、结节型或雀斑型)无关。具有早期转移高风险的恶性黑色素瘤的特征是氚标记胸腺嘧啶核苷的标记指数较高(大于1.5%),且合成DNA的黑色素瘤细胞数量较多(在肿瘤侧缘大于40/mm²)。

相似文献

1
The proliferative activity of cells of malignant melanomas.恶性黑色素瘤细胞的增殖活性。
Am J Dermatopathol. 1984 Summer;6 Suppl:317-23.
2
Differences in chromosomal aberrations between nodular and superficial spreading malignant melanoma detected by interphase cytogenetics.通过间期细胞遗传学检测发现的结节型和浅表扩散型恶性黑色素瘤之间的染色体畸变差异。
Lab Invest. 1998 Jul;78(7):883-8.
3
Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.晚期浅表扩散性恶性黑色素瘤细胞质中β-连环蛋白表达降低。
Clin Cancer Res. 2003 Aug 15;9(9):3383-8.
4
Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?皮肤黑素细胞肿瘤中Ki-67与p53免疫标记的同时检测:恶性黑色素瘤垂直生长期识别的辅助手段?
Mod Pathol. 2000 Mar;13(3):217-22. doi: 10.1038/modpathol.3880040.
5
[Malignant melanoma].[恶性黑色素瘤]
Ann Chir Plast Esthet. 1998 Aug;43(4):411-20.
6
The histopathology of cutaneous malignant melanoma.皮肤恶性黑色素瘤的组织病理学
Semin Diagn Pathol. 1993 Feb;10(1):47-75.
7
Invasive malignant melanomas lacking competence for metastasis.缺乏转移能力的侵袭性恶性黑色素瘤。
Am J Dermatopathol. 1984 Summer;6 Suppl:55-61.
8
Patterns of detection of superficial spreading and nodular-type melanoma: a multicenter Italian study.浅表扩散型和结节型黑色素瘤的检测模式:一项意大利多中心研究。
Dermatol Surg. 2004 Nov;30(11):1371-5; discussion 1375-6. doi: 10.1111/j.1524-4725.2004.30434.x.
9
Biological behavior and natural course of acral malignant melanoma. Clinical and histologic features and prognosis of palmoplantar, subungual, and other acral malignant melanomas.肢端恶性黑色素瘤的生物学行为及自然病程。掌跖、甲下及其他肢端恶性黑色素瘤的临床和组织学特征及预后。
Am J Dermatopathol. 1984 Summer;6 Suppl:43-53.
10
Malignant melanoma of the foot. A clinicopathological study of 125 primary cutaneous malignant melanomas.足部恶性黑色素瘤。125例原发性皮肤恶性黑色素瘤的临床病理研究。
Acta Pathol Microbiol Scand A. 1980 Sep;88(5):275-83.

引用本文的文献

1
Dormancy of growth-stunted malignant melanoma: sustainable and smoldering patterns.生长受限型恶性黑色素瘤的休眠:持续和隐匿模式
Oncol Rev. 2014 Sep 23;8(2):252. doi: 10.4081/oncol.2014.252.
2
Cell proliferation in cutaneous malignant melanoma: relationship with neoplastic progression.皮肤恶性黑色素瘤中的细胞增殖:与肿瘤进展的关系。
ISRN Dermatol. 2012;2012:828146. doi: 10.5402/2012/828146. Epub 2012 Jan 11.
3
Thigmotropism of malignant melanoma cells.恶性黑色素瘤细胞的向触性
Dermatol Res Pract. 2012;2012:362784. doi: 10.1155/2012/362784. Epub 2011 Nov 17.
4
Smouldering malignant melanoma and metastatic dormancy: an update and review.潜伏性恶性黑色素瘤与转移休眠:最新进展与综述
Dermatol Res Pract. 2012;2012:461278. doi: 10.1155/2012/461278. Epub 2011 Nov 2.
5
Factor XIIIa-positive dendrocytes and proliferative activity of cutaneous cancers.凝血因子XIIIa阳性树突状细胞与皮肤癌的增殖活性
Virchows Arch. 1996 Sep;429(1):43-8. doi: 10.1007/BF00196819.
6
Shope papilloma cell and leukocyte proliferation in regressing and progressing lesions.消退期和进展期病变中的肖普乳头瘤细胞和白细胞增殖。
Am J Pathol. 1993 Feb;142(2):489-96.
7
Bcl-2 expression in human melanocytes and melanocytic tumors.Bcl-2在人黑素细胞和黑素细胞性肿瘤中的表达。
Am J Pathol. 1994 Aug;145(2):294-300.
8
The Ki-67 antigen in primary human melanomas--its relationship to mitotic rate and tumor thickness and its stability.
Arch Dermatol Res. 1989;281(3):173-7. doi: 10.1007/BF00456388.
9
Proliferative activity of cutaneous melanocytic neoplasms defined by a proliferating cell nuclear antigen labelling index.
Arch Dermatol Res. 1992;284(6):319-23. doi: 10.1007/BF00372033.